Literature DB >> 8692288

Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.

A H Abdelmawla1, R W Langley, E Szabadi, C M Bradshaw.   

Abstract

We have measured the diameter of the human dorsal hand vein (DHV) in situ and compared the venoconstrictor dose-response curves to locally infused noradrenaline at different venous congestion pressures using the DHV compliance technique. Congestion pressure was defined as the inflation pressure of a sphygmomanometer cuff on the ipsilateral upper arm. Male healthy volunteers (20-45 years) participated in two experimental sessions. In Session I, DHV diameter was measured at congestion pressures of 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70 mmHg. In Session II, venoconstrictor dose-response curves to six doses (0.1-33.33 ng min-1) of (-)noradrenaline acid tartrate were established at congestion pressures 30 and 45 mmHg. DHV diameter increased as a function of congestion pressure. The rate of increase in DHV diameter (mm/5 mmHg) declined at higher values of congestion pressure (e.g. 0.14 mm/5 mmHg between 20 and 45 mmHg, and 0.04 mm/5 mmHg between 45 and 70 mmHg). Noradrenaline was less potent at 45 mmHg than at 30 mmHg. Mean log ED50 was significantly greater at 45 mmHg than at 30 mmHg congestion pressure, while mean E(max) did not differ at the two congestion pressures. The geometric mean ED50 was approximately 195% greater at 45 mmHg than at 30 mmHg. These results show that DHV diameter is positively related to congestion pressure, and that as the congestion pressure increases, the apparent sensitivity of the vein to the venoconstrictor effect of noradrenaline decreases. This latter finding is consistent with the physiological antagonism between congestion-induced venodilatation and noradrenaline-evoked venoconstriction. It is recommended that a standard congestion pressure is used in order to facilitate the comparison of results obtained in different laboratories.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692288     DOI: 10.1007/bf00168635

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  Pharmacology of endothelin-1 in vivo in humans.

Authors:  W G Haynes; J G Clarke; J R Cockcroft; D J Webb
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity.

Authors:  A O Alradi; S G Carruthers
Journal:  Clin Pharmacol Ther       Date:  1985-11       Impact factor: 6.875

4.  Assessment of the effect of drugs on the venous system in man.

Authors:  B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

5.  Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

6.  Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.

Authors:  H G Eichler; G A Ford; T F Blaschke; A Swislocki; B B Hoffman
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 7.  The pharmacology of human blood vessels in vivo.

Authors:  D J Webb
Journal:  J Vasc Res       Date:  1995 Jan-Feb       Impact factor: 1.934

8.  Vascular alpha-adrenergic responsiveness is reduced in cirrhosis.

Authors:  G S Bierbrier; P C Adams; R D Feldman
Journal:  Clin Pharmacol Ther       Date:  1994-12       Impact factor: 6.875

9.  Effect of bradykinin on arteries and veins in systemic and pulmonary circulation.

Authors:  G Bönner; S Preis; U Schunk; M Wagmann; R Chrosch; C Toussaint
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

Review 10.  Clinical pharmacology, physiology and pathophysiology of superficial veins--1.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.